Author
Listed:
- Xiaomu Li
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong
Zhongshan Hospital, Fudan University)
- Kenneth K. Y. Cheng
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Zhuohao Liu
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Jin-Kui Yang
(Beijing Key Laboratory of Diabetes Research and Care, Beijing Tongren Hospital, Capital Medical University)
- Baile Wang
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Xue Jiang
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Yawen Zhou
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Philip Hallenborg
(University of Southern Denmark)
- Ruby L. C. Hoo
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Karen S. L. Lam
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong)
- Yasuhiro Ikeda
(Mayo Clinic)
- Xin Gao
(Zhongshan Hospital, Fudan University)
- Aimin Xu
(State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong
The University of Hong Kong
The University of Hong Kong)
Abstract
Mitochondrial metabolism is pivotal for glucose-stimulated insulin secretion (GSIS) in pancreatic β-cells. However, little is known about the molecular machinery that controls the homeostasis of intermediary metabolites in mitochondria. Here we show that the activation of p53 in β-cells, by genetic deletion or pharmacological inhibition of its negative regulator MDM2, impairs GSIS, leading to glucose intolerance in mice. Mechanistically, p53 activation represses the expression of the mitochondrial enzyme pyruvate carboxylase (PC), resulting in diminished production of the TCA cycle intermediates oxaloacetate and NADPH, and impaired oxygen consumption. The defective GSIS and mitochondrial metabolism in MDM2-null islets can be rescued by restoring PC expression. Under diabetogenic conditions, MDM2 and p53 are upregulated, whereas PC is reduced in mouse β-cells. Pharmacological inhibition of p53 alleviates defective GSIS in diabetic islets by restoring PC expression. Thus, the MDM2–p53–PC signalling axis links mitochondrial metabolism to insulin secretion and glucose homeostasis, and could represent a therapeutic target in diabetes.
Suggested Citation
Xiaomu Li & Kenneth K. Y. Cheng & Zhuohao Liu & Jin-Kui Yang & Baile Wang & Xue Jiang & Yawen Zhou & Philip Hallenborg & Ruby L. C. Hoo & Karen S. L. Lam & Yasuhiro Ikeda & Xin Gao & Aimin Xu, 2016.
"The MDM2–p53–pyruvate carboxylase signalling axis couples mitochondrial metabolism to glucose-stimulated insulin secretion in pancreatic β-cells,"
Nature Communications, Nature, vol. 7(1), pages 1-14, September.
Handle:
RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11740
DOI: 10.1038/ncomms11740
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11740. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.